EV/EBITDA:
-14.96-0.21(-1.42%)Summary
- As of today, MLYS EV/EBITDA is -14.96, with a fall of -0.21 (-1.42%) during the most recent trading session on October 15, 2025.
- Over the past year, MLYS EV/EBITDA has dropped by -12.41 (-486.67%).
- MLYS EV/EBITDA is now -11607.69% below its all-time high of 0.13.
Performance
MLYS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
MLYS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | -1.4% | +1.4% | +1.3% |
| 1M1 Month | -17.8% | +17.8% | +15.8% |
| 3M3 Months | -392.1% | +392.9% | +202.7% |
| 6M6 Months | -466.7% | +470.1% | +221.1% |
| YTDYTD | -592.6% | +631.8% | +252.2% |
| 1Y1 Year | -486.7% | +606.5% | +211.0% |
| 5Y5 Years | - | - | - |
MLYS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -12.24 | -22.2% | -14.96 | at low |
| 3M | 3-Month | -2.60 | -475.4% | -14.96 | at low |
| 6M | 6-Month | -2.55 | -486.7% | -14.96 | at low |
| 1Y | 1-Year | -1.24 | -1106.5% | -14.96 | at low |
| 3Y | 3-Year | 0.13 | >-9999.0% | -28.10 | +46.8% |
| 5Y | 5-Year | 0.13 | >-9999.0% | -28.10 | +46.8% |
| All-Time | All-Time | 0.13 | >-9999.0% | -28.10 | +46.8% |
MLYS EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -14.96(-592.6%) |
| Date | Value |
|---|---|
| 2024 | -2.16(-56.5%) |
| 2023 | -1.38 |
FAQ
- What is Mineralys Therapeutics, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Mineralys Therapeutics, Inc.?
- What is MLYS EV/EBITDA year-to-date change?
- What is Mineralys Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Mineralys Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of MLYS is -14.96
What is the all-time high EV/EBITDA for Mineralys Therapeutics, Inc.?
Mineralys Therapeutics, Inc. all-time high EV/EBITDA is 0.13
What is MLYS EV/EBITDA year-to-date change?
Mineralys Therapeutics, Inc. EV/EBITDA has changed by -12.80 (-592.59%) since the beginning of the year
What is Mineralys Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, MLYS EV/EBITDA has changed by -12.41 (-486.67%)